|
|
| PLD1_RAT |
Pld1 |
Phospholipase D1 |
3.031e-97 |
0.34
|
| PLD2_HUMAN |
PLD2 |
Phospholipase D2 |
6.484e-61 |
0.35
|
| PLD1_HUMAN |
PLD1 |
Phospholipase D1 |
6.832e-56 |
0.36
|
| CP2J2_HUMAN |
CYP2J2 |
Cytochrome P450 2J2 |
2.448e-55 |
0.33
|
| 5HT4R_MOUSE |
Htr4 |
5-hydroxytryptamine receptor 4 |
2.633e-49 |
0.32
|
| OPRX_HUMAN |
OPRL1 |
Nociceptin receptor |
1.722e-44 |
0.47
|
| NPSR1_RAT |
Npsr1 |
Neuropeptide S receptor |
6.145e-36 |
0.28
|
| OPRM_HUMAN |
OPRM1 |
Mu-type opioid receptor |
8.766e-24 |
0.56
|
| 5HT4R_CAVPO |
HTR4 |
5-hydroxytryptamine receptor 4 |
1.195e-21 |
0.46
|
| HRH3_CAVPO |
HRH3 |
Histamine H3 receptor |
4.825e-20 |
0.37
|
| MEN1_HUMAN |
MEN1 |
Menin |
3.427e-17 |
0.32
|
| NPSR1_HUMAN |
NPSR1 |
Neuropeptide S receptor |
2.22e-16 |
0.30
|
| CCR1_HUMAN |
CCR1 |
C-C chemokine receptor type 1 |
3.331e-16 |
0.41
|
| OGRL1_HUMAN |
OGFRL1 |
Opioid growth factor receptor-like protein 1 |
5.884e-15 |
0.31
|
| Q8VH26_CAVPO |
GPM3 |
Muscarinic acetylcholine receptor |
2.287e-14 |
0.48
|
| ACM1_HUMAN |
CHRM1 |
Muscarinic acetylcholine receptor M1 |
7.094e-14 |
0.38
|
| ACM3_HUMAN |
CHRM3 |
Muscarinic acetylcholine receptor M3 |
3.864e-13 |
0.38
|
| KCNA3_HUMAN |
KCNA3 |
Potassium voltage-gated channel subfamily A member 3 |
1.645e-12 |
0.54
|
| DCNL1_HUMAN |
DCUN1D1 |
DCN1-like protein 1 |
1.093e-11 |
0.30
|
| ACM2_HUMAN |
CHRM2 |
Muscarinic acetylcholine receptor M2 |
1.124e-11 |
0.48
|
| SCN2A_RAT |
Scn2a |
Sodium channel protein type 2 subunit alpha |
1.747e-11 |
0.35
|
| ANM6_HUMAN |
PRMT6 |
Protein arginine N-methyltransferase 6 |
2.407e-11 |
0.33
|
| CALM_BOVIN |
CALM |
Calmodulin |
3.928e-11 |
0.30
|
| KCNK2_HUMAN |
KCNK2 |
Potassium channel subfamily K member 2 |
6.22e-10 |
0.31
|
| NMD3A_RAT |
Grin3a |
Glutamate receptor ionotropic, NMDA 3A |
6.538e-10 |
0.29
|
| CARM1_HUMAN |
CARM1 |
Histone-arginine methyltransferase CARM1 |
1.785e-09 |
0.33
|
| ACM4_HUMAN |
CHRM4 |
Muscarinic acetylcholine receptor M4 |
2.114e-08 |
0.35
|
| CAC1G_HUMAN |
CACNA1G |
Voltage-dependent T-type calcium channel subunit alpha-1G |
4.491e-08 |
0.32
|
| DRD3_CHLAE |
DRD3 |
D(3) dopamine receptor |
4.951e-08 |
0.28
|
| ACM5_HUMAN |
CHRM5 |
Muscarinic acetylcholine receptor M5 |
6.954e-08 |
0.35
|
| ADA1D_HUMAN |
ADRA1D |
Alpha-1D adrenergic receptor |
1.197e-07 |
0.33
|
| HRH1_CAVPO |
HRH1 |
Histamine H1 receptor |
2.059e-07 |
0.32
|
| ACM4_RAT |
Chrm4 |
Muscarinic acetylcholine receptor M4 |
4.855e-07 |
0.31
|
| NK2R_HUMAN |
TACR2 |
Substance-K receptor |
7.514e-07 |
0.33
|
| UBE2N_HUMAN |
UBE2N |
Ubiquitin-conjugating enzyme E2 N |
1.302e-06 |
0.33
|
| ADA1B_HUMAN |
ADRA1B |
Alpha-1B adrenergic receptor |
1.306e-06 |
0.33
|
| NPY5R_RAT |
Npy5r |
Neuropeptide Y receptor type 5 |
2.049e-06 |
0.29
|
| ACM5_RAT |
Chrm5 |
Muscarinic acetylcholine receptor M5 |
2.849e-06 |
0.29
|
| ADA1B_RAT |
Adra1b |
Alpha-1B adrenergic receptor |
3.342e-06 |
0.33
|
| DRD4_HUMAN |
DRD4 |
D(4) dopamine receptor |
3.978e-06 |
0.33
|
| ADA1A_HUMAN |
ADRA1A |
Alpha-1A adrenergic receptor |
4.385e-06 |
0.33
|
| NK3R_HUMAN |
TACR3 |
Neuromedin-K receptor |
5.511e-06 |
0.33
|